2Beijing Collaborative Study Group of Coronary Heart Disease 100700 (correspondewce: Beijing General Hospital, PLA, Beijing 100700).女性急性心肌梗塞的临床特点[J].中华心血管病杂志,1998,26(3):175-177. 被引量：47
2Barrett-Connor E, Grady D. Hormone replacement therapy, heart disease,and other consideration [ J ]. Annu Rev Public Health, 1998, 19(1) :55-72.
3Mendelsoho ME, Karas RH. Estrogen and blood vessel wall [ J ]. Curr Opin Cardiol,1994,9(5) :619-626.
4Rifkind BM. High-density lipoprotein Cholesterol and corttary artery disease:survey of the evidence[J]. Am J Cardiol, 1990,66( 1 ) :34-42.
5Mattews KA, Menlahn H, Kuller LH, et al. Menopause and risk factors for coronary heary disease[J]. N Engl J Med, 1987,321(3) :641-650.
6Hong MK, Romm RA, Reagan K, et al. Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women[J]. Am J Cardiol, 1992,69(2) :176.
7Shlipak MG, Simon JA, Vittinghoff E, et al. Estrogen and progestin, lipoprotein(a), and the risk of recurrent coronary heart disease events afer menopause[J]. JAMA ,2002,283(10) : 1845-1852.
8Shono N, Kumagai S, Higaki Y, et al. The relationships of teatosterons,estradiol, dehydroepian drosteroue sulfate and sex hormone-binding globulin to lipid and glucose metabolism in health meal J] .J Atheroscoer Thromb, 1996,3( 1 ) :45-51.
9Mograno MM, Chang W, Katzenellenbogeu BS, et al. An estrogen receptor-selective corepressor:Cloning and Characterization[J]. Endocrinol, 1998,98( 1 ) :96-106.
10Shwaery GT, Vita JA, Keaney JF Jr. Antioxidant protection of LDL by physiological concentrations of 17 β-estradiol:requiremont for estradiol modification [ J ]. Circulation, 1997,95 (8) : 1378-1385.
